Skip to content

Effect of Smartphone Application Kin Ya Ka Na to Improve Medication Adherence in Patients with Schizophrenia: Randomized Controlled Trial.

Effect of Smartphone Application Kin Ya Kan Na to Improve Medication Adherence in Patients with Schizophrenia: Randomized Controlled Trial.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20221108003
Enrollment
84
Registered
2022-11-08
Start date
2022-10-17
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with Schizophrenia who received outpatient treatment at the Mental Health and Psychiatric Department, Buddhasothorn Hospital, Chachoengsao province. And had previous histories of medication nonadherence. smartphone application medication adherence patients with schizophrenia

Interventions

Medication self-management application for patients with Schizophrenia. This application developed by integrating the concepts of self-regulation, social support, and empirical evidences.,Regular nurs
Experimental Behavioral,No Intervention Other
Kin ya kan na application,Usual care

Sponsors

Faculty of Nursing Burapha University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 59 Years

Inclusion criteria

Inclusion criteria: 1) Age between 20-59 years old. 2) During the past 6 months, there was a history of missing medication or taking medicines that didn't meet the treatment plan due to inattention, such as forgetfulness, neglect, or misunderstandings during medication intake. 3) Acknowledging an illness and without severe psychiatric remnants that affect one's ability to care for oneself, such as a distorted perception of reality due to delusions, hallucinations, or aggressive behavior. 4) Have and be able to use a smartphone in Android operating system. 5) Willing to voluntarily participate in research.

Exclusion criteria

Exclusion criteria: 1) Treated with injectable psychiatric drugs only. 2) Had a recurrence of severe psychotic symptoms that affected their ability to participate in the study.

Design outcomes

Primary

MeasureTime frame
Medication adherence behavior 2 times ( At the beginning of study and the end of study at week 12) Medication Adherence Scale in Thais: MAST

Secondary

MeasureTime frame
Application user satisfaction 1 time (at the end of this study at week 12) Guidelines for evaluation the usability of mHealth questionnaire

Countries

Thailand

Contacts

Public ContactPornpun Sudjai

Faculty of nursing, Burapha University

medicgift@hotmail.com0646289747

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026